8840 related articles for article (PubMed ID: 12380046)
1. Risk factors for the development of primary cutaneous malignant melanoma.
MacKie RM
Dermatol Clin; 2002 Oct; 20(4):597-600. PubMed ID: 12380046
[TBL] [Abstract][Full Text] [Related]
2. Genetic and environmental factors in cutaneous malignant melanoma.
Bressac-de-Paillerets B; Avril MF; Chompret A; Demenais F
Biochimie; 2002 Jan; 84(1):67-74. PubMed ID: 11900878
[TBL] [Abstract][Full Text] [Related]
3. [Of mice and humans. Updates on susceptibility and tumor suppression of malignant melanoma].
Hautarzt; 2002 Jan; 53(1):88-9. PubMed ID: 11968172
[No Abstract] [Full Text] [Related]
4. Genetic susceptibility in familial melanoma from northeastern Italy.
Landi MT; Goldstein AM; Tsang S; Munroe D; Modi W; Ter-Minassian M; Steighner R; Dean M; Metheny N; Staats B; Agatep R; Hogg D; Calista D
J Med Genet; 2004 Jul; 41(7):557-66. PubMed ID: 15235029
[No Abstract] [Full Text] [Related]
5. Genetics of melanoma predisposition.
Hayward NK
Oncogene; 2003 May; 22(20):3053-62. PubMed ID: 12789280
[TBL] [Abstract][Full Text] [Related]
6. Genes involved in melanoma: an overview of INK4a and other loci.
Castellano M; Parmiani G
Melanoma Res; 1999 Oct; 9(5):421-32. PubMed ID: 10596908
[TBL] [Abstract][Full Text] [Related]
7. [The INK4a-ARF locus: role in the genetic predisposition to familial melanoma and in skin carcinogenesis].
Soufir N; Basset-Seguin N
Bull Cancer; 2001 Nov; 88(11):1061-7. PubMed ID: 11741799
[TBL] [Abstract][Full Text] [Related]
8. Melanoma candidate genes CDKN2A/p16/INK4A, p14ARF, and CDK4 sequencing in patients with uveal melanoma with relative high-risk for hereditary cancer predisposition.
Abdel-Rahman MH; Pilarski R; Massengill JB; Christopher BN; Noss R; Davidorf FH
Melanoma Res; 2011 Jun; 21(3):175-9. PubMed ID: 21412176
[TBL] [Abstract][Full Text] [Related]
9. Genotype-phenotype relationships in U.S. melanoma-prone families with CDKN2A and CDK4 mutations.
Goldstein AM; Struewing JP; Chidambaram A; Fraser MC; Tucker MA
J Natl Cancer Inst; 2000 Jun; 92(12):1006-10. PubMed ID: 10861313
[TBL] [Abstract][Full Text] [Related]
10. Genetic study of familial uveal melanoma: association of uveal and cutaneous melanoma with cutaneous and ocular nevi.
Smith JH; Padnick-Silver L; Newlin A; Rhodes K; Rubinstein WS
Ophthalmology; 2007 Apr; 114(4):774-9. PubMed ID: 17207529
[TBL] [Abstract][Full Text] [Related]
11. Molecular genetics of familial cutaneous melanoma.
Haluska FG; Hodi FS
J Clin Oncol; 1998 Feb; 16(2):670-82. PubMed ID: 9469357
[TBL] [Abstract][Full Text] [Related]
12. American Academy of Dermatology 1999 Awards for Young Investigators in Dermatology. Targets of genetic injury in cutaneous melanoma.
Tsao H
J Am Acad Dermatol; 1999 Sep; 41(3 Pt 1):459-61. PubMed ID: 10507912
[No Abstract] [Full Text] [Related]
13. Vitamin D receptor variants and the malignant melanoma risk: a population-based study.
Gapska P; Scott RJ; Serrano-Fernandez P; Mirecka A; Rassoud I; Górski B; Cybulski C; Huzarski T; Byrski T; Nagay L; Maleszka R; Sulikowski M; Lubinski J; Debniak T
Cancer Epidemiol; 2009 Aug; 33(2):103-7. PubMed ID: 19679055
[TBL] [Abstract][Full Text] [Related]
14. Individuals with presumably hereditary uveal melanoma do not harbour germline mutations in the coding regions of either the P16INK4A, P14ARF or cdk4 genes.
Soufir N; Bressac-de Paillerets B; Desjardins L; Lévy C; Bombled J; Gorin I; Schlienger P; Stoppa-Lyonnet D
Br J Cancer; 2000 Feb; 82(4):818-22. PubMed ID: 10732752
[TBL] [Abstract][Full Text] [Related]
15. Clinical and histologic characteristics of malignant melanoma in families with a germline mutation in CDKN2A.
van der Rhee JI; Krijnen P; Gruis NA; de Snoo FA; Vasen HFA; Putter H; Kukutsch NA; Bergman W
J Am Acad Dermatol; 2011 Aug; 65(2):281-288. PubMed ID: 21570156
[TBL] [Abstract][Full Text] [Related]
16. Genetic epidemiology of cutaneous melanoma: a global perspective.
Goldstein AM; Tucker MA
Arch Dermatol; 2001 Nov; 137(11):1493-6. PubMed ID: 11708953
[No Abstract] [Full Text] [Related]
17. Genetic testing in hereditary melanoma.
Tsao H; Niendorf K
J Am Acad Dermatol; 2004 Nov; 51(5):803-8. PubMed ID: 15523363
[TBL] [Abstract][Full Text] [Related]
18. Expression and localization of mutant p16 proteins in melanocytic lesions from familial melanoma patients.
Ghiorzo P; Villaggio B; Sementa AR; Hansson J; Platz A; Nicoló G; Spina B; Canepa M; Palmer JM; Hayward NK; Bianchi-Scarrà G
Hum Pathol; 2004 Jan; 35(1):25-33. PubMed ID: 14745721
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of germline CDKN2A, ARF, CDK4, PTEN, and BRAF alterations in atypical mole syndrome.
Celebi JT; Ward KM; Wanner M; Polsky D; Kopf AW
Clin Exp Dermatol; 2005 Jan; 30(1):68-70. PubMed ID: 15663508
[TBL] [Abstract][Full Text] [Related]
20. Impaired processing of DNA photoproducts and ultraviolet hypermutability with loss of p16INK4a or p19ARF.
Sarkar-Agrawal P; Vergilis I; Sharpless NE; DePinho RA; Rünger TM
J Natl Cancer Inst; 2004 Dec; 96(23):1790-3. PubMed ID: 15572761
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
